Applications of Ethylestrenol in Industrial Manufacturing

Ethylestrenol serves as a specialized synthetic steroidal raw material with regulated industrial applications. Our manufacturing practice aligns with global pharmaceutical standards to support responsible downstream use. We provide consistent quality for approved production lines where this material holds valid technical functions.

1. Pharmaceutical API Synthesis – Anabolic Steroid Formulation

The primary downstream use for ethylestrenol is in the synthesis of anabolic steroid pharmaceutical APIs, particularly in the preparation of oral formulations. Our API-grade ethylestrenol integrates into cGMP-compliant production flows for manufacturing regulated steroidal medicinal products. It undergoes strict release testing under validated analytical methods as required for active pharmaceutical ingredient assembly. Our customers process this material under closed-system environments, maintaining batch traceability for each stage of drug synthesis leading to finished dosage forms.

Industry compliance standards

• cGMP (ICH Q7 and 21 CFR Parts 210/211) for API manufacture
• European Pharmacopoeia Monograph 01/2008:1086 for Ethylestrenol
• US Pharmacopeia where listed in registered monographs
• EMA and FDA regulatory submission guidance for steroid-based actives
• Local Drug Administration manufacturing licensing

Typical usage ratio

• Typically 10–40 mg per finished tablet unit; bulk product batches use 2–15% API by weight, adjusted according to drug formulation design and regulatory strength requirements

Downstream process integration

• Material dispensed in controlled dispensing rooms
• Integrated during granulation or direct compression for solid oral dosage forms
• API and excipients blended following validated protocols
• In-process controls performed for blend uniformity and content assay

Final product types

• Prescription anabolic steroid tablets
• Specialty hormonal oral medications under national medical supervision

2. Veterinary Steroid Preparations for Large Animal Health

Ethylestrenol is utilized in veterinary medicine sectors where legal, for formulating steroid hormonal agents targeting bovine, canine, and equine applications. This material enters veterinary compounding streams in compliance with animal health product regulatory frameworks. It is formulated exclusively by authorized veterinarians or veterinary pharmaceutical manufacturers for select livestock health interventions, mostly as adjunct agents for appetite stimulation or anabolic support, subject to strict residue and withdrawal controls.

Industry compliance standards

• VICH GL9 (Good Manufacturing Practice for Veterinary Products)
• FDA 21 CFR 514.1 and CVM guidelines for veterinary drug approvals
• EU Regulation (EC) No 726/2004 for veterinary medicinal products
• National Agricultural and Livestock Agency prescription controls
• Maximum residue limits (MRLs) as set by Codex Alimentarius

Typical usage ratio

• Final premix or injectable preparations: 1–5 mg/kg animal weight, with formulation concentrate typically at 0.1–1% by weight, tailored per species and treatment regimen

Downstream process integration

• Batch blending of actives into veterinary premix or injectable carrier
• Sterile filtration and aseptic filling for injectable forms
• Dispensing and dosing packaging in line with regulated veterinary compounding protocols

Final product types

• Veterinary anabolic steroid premixes
• Veterinary injectable suspensions for licensed large animals

3. Reference Material Supply for Certified Pharmaceutical Analytical Laboratories

Several certified pharmaceutical quality control and research laboratories procure ethylestrenol as a reference material or standard for validated analytical testing purposes. Accredited labs require this raw material in its highest purity to validate identity and content of finished pharmaceuticals or for residue studies in quality surveillance. Laboratories operate under ISO/IEC 17025 framework and national drug reference substance programs, applying rigorous documentation to ensure traceability of each batch used in calibrating QC instrumentation or in proficiency testing schemes.

Industry compliance standards

• ISO/IEC 17025 for laboratory accreditation
• Pharmacopoeial Reference Standards (Ph. Eur, USP, JP where applicable)
• National Institute for Food and Drug Control (NIFDC) requirements
• WHO Good Laboratory Practice (GLP) guidelines

Typical usage ratio

• Laboratory reference standards: 5–50 mg per QC batch, dependent on the method detection limit or assay validation protocol

Downstream process integration

• Weighting and solution preparation for HPLC, GC, or LC-MS calibration
• Preparation of working standard blends for routine quality batch testing
• Ongoing control sample archiving for traceability audits

Final product types

• Chemical reference standards
• Standardized stock solutions for Method Validation in QC laboratories

4. Doping Control and Sports Anti-Doping Laboratory Quality Assurance

WADA-accredited and national anti-doping laboratories source ethylestrenol for use as a certified calibration standard in testing programs for banned substances in sports. The material supports development and validation of detection methods for synthetic anabolic steroids within athlete biological samples under global anti-doping codes. Each delivery batch for these labs includes analytical certification, storage, and handling under strictly documented chain-of-custody requirements.

Industry compliance standards

• World Anti-Doping Agency (WADA) International Standard for Laboratories
• ISO 17034 for reference material producers
• ISO/IEC 17025 for competence of testing laboratories
• WADA Technical Documents for Identification of Prohibited Substances

Typical usage ratio

• Calibration or spiking solution preparation: 1–10 µg/mL in biological matrix; actual mass depends on LC-MS/MS or GC-MS method and sample load

Downstream process integration

• Preparation of analytical calibration curves for doping control analysis
• Reference standard addition in negative urine or serum samples for proficiency testing
• Routine sample authentication during WADA anti-doping compliance testing

Final product types

• Anti-doping testing kits
• Certified doping control reference blends for laboratory use